266 related articles for article (PubMed ID: 9525590)
21. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
Chazal N; Carrière C; Gay B; Boulanger P
J Virol; 1994 Jan; 68(1):111-22. PubMed ID: 8254720
[TBL] [Abstract][Full Text] [Related]
22. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
Ono A; Freed EO
J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
[TBL] [Abstract][Full Text] [Related]
23. Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.
Harila K; Prior I; Sjöberg M; Salminen A; Hinkula J; Suomalainen M
J Virol; 2006 Apr; 80(8):3765-72. PubMed ID: 16571793
[TBL] [Abstract][Full Text] [Related]
24. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
[TBL] [Abstract][Full Text] [Related]
25. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
Berkowitz RD; Luban J; Goff SP
J Virol; 1993 Dec; 67(12):7190-200. PubMed ID: 8230441
[TBL] [Abstract][Full Text] [Related]
26. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
Park J; Morrow CD
J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561
[TBL] [Abstract][Full Text] [Related]
27. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
Poon DT; Wu J; Aldovini A
J Virol; 1996 Oct; 70(10):6607-16. PubMed ID: 8794295
[TBL] [Abstract][Full Text] [Related]
28. trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.
Kaye JF; Lever AM
J Virol; 1996 Feb; 70(2):880-6. PubMed ID: 8551627
[TBL] [Abstract][Full Text] [Related]
29. Structural elements in the Gag polyprotein of feline immunodeficiency virus involved in Gag self-association and assembly.
Abdusetir Cerfoglio JC; González SA; Affranchino JL
J Gen Virol; 2014 Sep; 95(Pt 9):2050-2059. PubMed ID: 24854000
[TBL] [Abstract][Full Text] [Related]
30. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
31. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
Carrière C; Gay B; Chazal N; Morin N; Boulanger P
J Virol; 1995 Apr; 69(4):2366-77. PubMed ID: 7884882
[TBL] [Abstract][Full Text] [Related]
32. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
33. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.
Chen N; Morag A; Almog N; Blumenzweig I; Dreazin O; Kotler M
J Gen Virol; 2001 Mar; 82(Pt 3):581-590. PubMed ID: 11172099
[TBL] [Abstract][Full Text] [Related]
34. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Joshi A; Nagashima K; Freed EO
J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
[TBL] [Abstract][Full Text] [Related]
35. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis.
Strack B; Calistri A; Göttlinger HG
J Virol; 2002 Jun; 76(11):5472-9. PubMed ID: 11991975
[TBL] [Abstract][Full Text] [Related]
36. Subcellular localization of recombinant truncated Gag precursor proteins of HIV expressed in Saccharomyces cerevisiae.
Biemans R; Thines D; Gheysen D; Rutgers T; Cabezon T
AIDS; 1992 Jun; 6(6):541-6. PubMed ID: 1388874
[TBL] [Abstract][Full Text] [Related]
37. Identification of a minimal HIV-1 gag domain sufficient for self-association.
Zábranský A; Hunter E; Sakalian M
Virology; 2002 Mar; 294(1):141-50. PubMed ID: 11886273
[TBL] [Abstract][Full Text] [Related]
38. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
Lee YM; Tian CJ; Yu XF
J Virol; 1998 Nov; 72(11):9061-8. PubMed ID: 9765451
[TBL] [Abstract][Full Text] [Related]
39. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
Dorfman T; Luban J; Goff SP; Haseltine WA; Göttlinger HG
J Virol; 1993 Oct; 67(10):6159-69. PubMed ID: 8371356
[TBL] [Abstract][Full Text] [Related]
40. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
Colgan J; Yuan HE; Franke EK; Luban J
J Virol; 1996 Jul; 70(7):4299-310. PubMed ID: 8676452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
